The Effect of Gum Olibanum on blood glucose

The Effect of Gum Olibanum on FBS and Glycosilated Hemoglobine(HbA1c) in Type II Diabetic Patient

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201112078318N1

Enrollment

Registered

2012-03-08

Start date

2011-11-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II Diabetic. Non-insulin-dependent diabetes mellitus

Interventions

Treatment - Drugs

Placebo

Placebo two times per day for 12 weeks

Gum Olibanum (400 mg cap) two times per day for 12 weeks

Intervention 1: Gum Olibanum (400 mg cap) two times per day for 12 weeks. Intervention 2: Placebo two times per day for 12 weeks.

Eligibility

Sex/Gender

All

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Suffering from type II diabetic with fasting blood glucose 140-200 Exclusion criteria: Pregnant and nursing women; People under 18 years old and above 65 years old; In case of intensive diabetic; Using drugs which affect blood glucose like edible and positional Steroid; Diuretics drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
FBS level. Timepoint: After 12 Weeks of taking drug. Method of measurement: glucometer.;HbA1c level. Timepoint: After 12 Weeks of taking drug. Method of measurement: Laboratory kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Amir ziaee

Qazvin University of Medical Sciences

aazadmehr@qums.ac.ir+98 28 1336 0084

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026